{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:03:25Z","timestamp":1790237005794,"version":"4.1.0"},"reference-count":36,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Fear of cancer recurrence (FCR) is a prevalent concern among cancer survivors. Although evidence-based FCR guidelines exist, their implementation requires further operationalization. This study aimed to establish expert consensus on a clinical pathway to operationalize guideline-concordant FCR care in Denmark.\nPatient\/material and methods: A modified Delphi study was conducted, comprising Round 0 and three Delphi rounds. In Round 1, 112 experts were invited, and 80 participated (71%) in an online survey rating proposed pathway statements. Twenty-seven participants attended a consensus workshop (Round 2) to discuss and refine statements not reaching consensus in Round 1. In Round 3, 71 participants (63%) re-rated the revised statements from Round 2. Consensus was defined as \u2265\u200980% agreement.Results: Consensus was achieved for 10 statements in Round 1 and 6 revised or newly formulated statements in Round 3, including systematic screening of all cancer survivors with validated tools using a two-step approach, and initiation of screening at transition from treatment to follow-up. Consensus was achieved for need-based assessment guided by symptom severity and patient-expressed need. A matched-care model, aligning treatment intensity with FCR severity, achieved consensus in Round 1. Ongoing monitoring through re-screening during follow-up and post-intervention was endorsed. Timing of assessment and the management of FCR treatment non-response did not reach consensus.Interpretation: This Delphi study provides a consensus-based clinical pathway for FCR, including systematic screening, needs-based assessment, and matched-care allocation. The findings address key implementation gaps in existing FCR guidelines and offer a structured framework for integrating FCR care into routine practice.<\/jats:p>","DOI":"10.2340\/1651-226x.2026.46444","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:56:24Z","timestamp":1790236584000},"page":"792-801","source":"Crossref","is-referenced-by-count":0,"title":["Operationalizing fear of cancer recurrence care: a modified Delphi study establishing a consensus-based clinical pathway for Danish cancer survivors"],"prefix":"10.2340","volume":"65","author":[{"given":"Johanne Dam","family":"Lyhne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rames Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Maar Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Katrine","family":"Hartmann S\u00f8by","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"R Villumsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Vind Thaysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sandholdt Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iben","family":"Husted Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Otto Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Skov Rahb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Lynge Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Ventzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Henrik","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriseld","family":"Krasniqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan 'Ben'","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bonde Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"169289","doi-asserted-by":"crossref","unstructured":"Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265\u20138.","DOI":"10.1007\/s00520-016-3272-5"},{"key":"169290","doi-asserted-by":"crossref","unstructured":"Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WWT, Lebel S. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology. 2022;31(6):879\u201392.","DOI":"10.1002\/pon.5921"},{"key":"169291","doi-asserted-by":"crossref","unstructured":"Lisy K, Langdon L, Piper A, Jefford M. Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review. Asia-Pacific J Clin Oncol. 2019;15(5):e68\u201378.","DOI":"10.1111\/ajco.13176"},{"key":"169292","doi-asserted-by":"crossref","unstructured":"Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300\u201322.","DOI":"10.1007\/s11764-013-0272-z"},{"key":"169293","doi-asserted-by":"crossref","unstructured":"Lyhne JD, Jensen LH, Fink P, Timm S, Frostholm L, Smith A. Fear of cancer recurrence in long-term colorectal cancer survivors: a nationwide cross-sectional study. J Cancer Surviv. 2025;20:1431-42.","DOI":"10.1007\/s11764-025-01746-z"},{"key":"169294","doi-asserted-by":"crossref","unstructured":"Williams JTW, Pearce A, Smith A. A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness. Psychooncology. 2021;30(8):1185\u201395.","DOI":"10.1002\/pon.5673"},{"key":"169295","doi-asserted-by":"crossref","unstructured":"Vandraas K, Reinertsen KV, Smedsland S, B\u00f8hn S, Kiserud C, Falk RS, et al. Fear of cancer recurrence eight years after early-stage breast cancer \u2013 results from a national survey. Acta Oncol. 2023;62(6):635\u201341.","DOI":"10.1080\/0284186X.2023.2224052"},{"key":"169296","doi-asserted-by":"crossref","unstructured":"Shaw J, Kamphuis H, Sharpe L, Lebel S, Smith AB, Hulbert-Williams N, et al. Setting an international research agenda for fear of cancer recurrence: an online Delphi consensus study. Front Psychol. 2021;12:596682.","DOI":"10.3389\/fpsyg.2021.596682"},{"key":"169297","doi-asserted-by":"crossref","unstructured":"Rudy L, Maheu C, K\u00f6rner A, Lebel S, G\u00e9linas C. The FCR-1: initial validation of a single-item measure of fear of cancer recurrence. Psychooncology. 2020;29(4):788\u201395.","DOI":"10.1002\/pon.5350"},{"key":"169298","doi-asserted-by":"crossref","unstructured":"Smith AB, Gao M, Tran M, Ftanou M, Jegathees S, Wu V, et al. Evaluation of the validity and screening performance of a revised single\u2010item fear of cancer recurrence screening measure (FCR\u20101r). Psychooncology. 2023 Jun;32(6):961-71.","DOI":"10.1002\/pon.6139"},{"key":"169299","doi-asserted-by":"crossref","unstructured":"Lyhne JD, Smith AB, Timm S, Simard S, Jensen LH, Frostholm L, et al. Validity and screening capacity of the FCR-1r for fear of cancer recurrence in long-term colorectal cancer survivors. Support Care Cancer. 2023;31(12):690.","DOI":"10.1007\/s00520-023-08159-7"},{"key":"169300","doi-asserted-by":"crossref","unstructured":"Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho-oncology. 2012;21(6):571\u201387.","DOI":"10.1002\/pon.2070"},{"key":"169301","doi-asserted-by":"crossref","unstructured":"Tauber NM, O\u2019Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899\u2013915.","DOI":"10.1200\/JCO.19.00572"},{"key":"169302","unstructured":"Lebel CZS, Craig L, Conrod R, Freeman L, Galica J, Maheu C, et al. Fear of Cancer recurrence guideline 2024. [cited 2024 Oct 8]. Available from: https:\/\/www.cancercareontario.ca\/en\/guidelines-advice\/."},{"key":"169303","unstructured":"DMCG. Angst, depression og frygt for tilbagefald af kr\u00e6ft 2025. [cited 2025 Aug 22]. Available from: https:\/\/www.dmcg.dk\/siteassets\/kliniske-retningslinjer\/opdelt-paa-dmcg\/tvargaende-retningslinjer\/tvarg_rl_angst_depr_v1.0_admgodk220825.pdf"},{"key":"169304","doi-asserted-by":"crossref","unstructured":"Smith AB, Girgis A, Taylor N, Pearce A, Liu J, Shepherd HL, et al. Step-by-step: a clinical pathway for stepped care management of fear of cancer recurrence \u2013 results of a three-round online delphi consensus process with Australian health professionals and researchers. J Cancer Survivor. 2024;20:766-80.","DOI":"10.1007\/s11764-024-01685-1"},{"key":"169305","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND\/UCLA appropriateness method user\u2019s manual. RAND. Santa Monica, California. 2001."},{"key":"169306","doi-asserted-by":"crossref","unstructured":"Shaw JM, Price MA, Clayton JM, Grimison P, Shaw T, Rankin N, et al. Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process. Support Care Cancer. 2016;24(1):33\u201341.","DOI":"10.1007\/s00520-015-2742-5"},{"key":"169307","doi-asserted-by":"crossref","unstructured":"J\u00fcnger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review. Palliat Med. 2017;31(8):684\u2013706.","DOI":"10.1177\/0269216317690685"},{"key":"169308","doi-asserted-by":"crossref","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010;182(10):1045\u201352.","DOI":"10.1503\/cmaj.091714"},{"key":"169309","doi-asserted-by":"crossref","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010;182(10):E472\u20138.","DOI":"10.1503\/cmaj.091716"},{"key":"169310","doi-asserted-by":"crossref","unstructured":"Phillips B, Ball C, Badenoch D, Straus S, Haynes B, Dawes M. Oxford centre for evidence-based medicine levels of evidence (May 2001). BJU Int. 2011;107(5):870.","DOI":"10.1111\/j.1464-410X.2011.10141.x"},{"key":"169311","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"169312","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"169313","doi-asserted-by":"crossref","unstructured":"Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241\u201351.","DOI":"10.1007\/s00520-008-0444-y"},{"key":"169314","doi-asserted-by":"crossref","unstructured":"Liu JJ, Butow P, Beith J. Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors. Support Care Cancer. 2019;27(11):4055\u201367.","DOI":"10.1007\/s00520-019-04979-8"},{"key":"169315","doi-asserted-by":"crossref","unstructured":"Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G. Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psycho-oncology. 2020;29(2):430\u20136.","DOI":"10.1002\/pon.5283"},{"key":"169316","doi-asserted-by":"crossref","unstructured":"Luigjes-Huizer YL, van der Lee ML, Richel C, Masselink RA, de Wit NJ, Helsper CW. Patient-reported needs for coping with worry or fear about cancer recurrence and the extent to which they are being met: a survey study. J Cancer Survivor. 2024;18(3):791\u20139.","DOI":"10.1007\/s11764-022-01326-5"},{"key":"169317","unstructured":"Sundhedsministeriet I-O. Et bedre liv med og efter kr\u00e6ft \u2013 Kr\u00e6ftplan V. 2025 [cited 2026 Jan 10]. Available from: https:\/\/www.ism.dk\/publikationer-sundhed\/2025\/maj\/et-bedfre-liv-med-og-efter-kraeft"},{"key":"169318","doi-asserted-by":"crossref","unstructured":"Abdalla T, Singh GK, Pourali Roudbaneh S, Serwaa D, Peate M. Stepped-care models for cancer symptom management: a systematic review of efficacy and cost-effectiveness. J Natl Cancer Inst. 2026;118(1):26\u201348.","DOI":"10.1093\/jnci\/djaf153"},{"key":"169319","doi-asserted-by":"crossref","unstructured":"Tremblay D, Touati N, Bilodeau K, Prady C, Usher S, Leblanc Y. Risk-stratified pathways for cancer survivorship care: insights from a deliberative multi-stakeholder consultation. Curr Oncol (Toronto, Ont). 2021;28(5):3408\u201319.","DOI":"10.3390\/curroncol28050295"},{"key":"169320","doi-asserted-by":"crossref","unstructured":"Andersen BL, Lacchetti C, Ashing K, Berek JS, Berman BS, Bolte S, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023;41(18):3426\u201353.","DOI":"10.1200\/JCO.23.00293"},{"key":"169321","doi-asserted-by":"crossref","unstructured":"Pradhan P, Sharpe L, Menzies RE. Towards a stepped care model for managing fear of cancer recurrence or progression in cancer survivors. Cancer Manag Res. 2021;13:8953\u201365.","DOI":"10.2147\/CMAR.S294114"},{"key":"169322","doi-asserted-by":"crossref","unstructured":"Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, et al. Feasibility and acceptability of fear-less: a stepped-care program to manage fear of cancer recurrence in people with metastatic melanoma. J Clin Med. 2020;9(9):2969.","DOI":"10.3390\/jcm9092969"},{"key":"169323","doi-asserted-by":"crossref","unstructured":"Kolsteren EEM, Deuning-Smit E, Chu AK, van der Hoeven YCW, Prins JB, van der Graaf WTA, et al. Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: a scoping review. Cancers. 2022 Aug 11;14(16):3889.","DOI":"10.3390\/cancers14163889"},{"key":"169324","unstructured":"Ministero della Salute. Piano Oncologico Nazionale: documento di pianificazione e indirizzo per la prevenzione e il contrasto del cancro 2023\u20132027. Rome, Italy (Roma): Ministero della Salute; 2023."}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/46444\/55615","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/46444\/55615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:56:37Z","timestamp":1790236597000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/46444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":36,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2026.46444","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}